Differences inp16Gene Methylation and Expression in Benign and Malignant Ovarian Tumors

By McCluskey L.L.   Chen C.   Delgadillo E.   Felix J.C.   Muderspach L.I.   Dubeau L.  

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography

By Ueland F.R.   DePriest P.D.   Pavlik E.J.   Kryscio R.J.   van Nagell J.R.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 46-50

Elsevier

Access to resources Recommend Favorite

CD31 Expression in Benign, Borderline, and Malignant Epithelial Ovarian Tumors: An Immunohistochemical and Serological Analysis

By Darai E.   Bringuier A.-F.   Walker-Combrouze F.   Fauconnier A.   Couvelard A.   Feldmann G.   Madelenat P.   Scoazec J.-Y.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 122-127

Elsevier

Access to resources Recommend Favorite

Subfertility and the risk of testicular germ cell tumors (United States)

By Doria-Rose V.  

Cancer Causes and Control, Vol. 16, Iss. 6, 2005-08 ,pp. : 651-656

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Progranulin (Acrogranin/PCDGF/Granulin-Epithelin Precursor) in Benign and Malignant Ovarian Tumors and Activation of MAPK Signaling in Ovarian Cancer Cell Line*

By Cuevas-Antonio R.   Cancino C.   Arechavaleta-Velasco F.   Andrade A.   Barron L.   Estrada I.   Fernandez R. L.   Olguin V.   Ruiz S.   Imani F.   Zeferino-Toquero M.   Ulloa-Aguirre A.   Gerton G. L.   Diaz-Cueto L.  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 452-458

Informa Healthcare

Access to resources Recommend Favorite